OCULAR FORMULATIONS WITH NEUROPROTECTANTS TO REDUCE ALZHEIMER AND NEUROTOXIC RISKS CREATED BY LARGE ZINC DOSAGES

摘要

This invention relates to pharmaceuticals and nutritional supplements, and to orally-ingested formulations comprising zinc, carotenes such as zeaxanthin and/or lutein, and reduced amounts of beta-carotene, for treating or preventing macular degeneration and other eye and vision-related disorders.